User profiles for Joanna Pepke-Zaba
Joanna Pepke-ZabaPapworth Hospital Verified email at virginmedia.com Cited by 90632 |
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary …
…, B Nagavci, KM Olsson, J Pepke-Zaba… - European heart …, 2022 - academic.oup.com
Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
clinical conditions and may be associated with a variety of cardiovascular and respiratory …
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
J Pepke-Zaba, TW Higenbottam, AT Dinh-Xuan… - The Lancet, 1991 - Elsevier
The acute effects of inhaled nitric oxide (NO) (40 ppm in air) on pulmonary (PVR) and
systemic (SVR) vascular resistance were compared with those of an intravenous infusion of …
systemic (SVR) vascular resistance were compared with those of an intravenous infusion of …
Chronic thromboembolic pulmonary hypertension (CTEPH) results from an international prospective registry
J Pepke-Zaba, M Delcroix, I Lang, E Mayer, P Jansa… - Circulation, 2011 - Am Heart Assoc
Background— Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel
of venous thromboembolism with fatal natural history; however, many cases can be cured by …
of venous thromboembolism with fatal natural history; however, many cases can be cured by …
[HTML][HTML] Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry
…, W Klepetko, M Delcroix, I Lang, J Pepke-Zaba… - The Journal of thoracic …, 2011 - Elsevier
OBJECTIVE: Pulmonary endarterectomy is a curative surgical treatment option for the majority
of patients with chronic thromboembolic pulmonary hypertension. The current surgical …
of patients with chronic thromboembolic pulmonary hypertension. The current surgical …
Connective tissue disease–associated pulmonary arterial hypertension in the modern treatment era
…, D Hodgkins, RJ Hughes, J Pepke-Zaba… - American journal of …, 2009 - atsjournals.org
Rationale: Pulmonary arterial hypertension in association with connective tissue disease (CTD-PAH)
has historically had a poor prognosis, with a 1-year survival rate among patients …
has historically had a poor prognosis, with a 1-year survival rate among patients …
Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension
…, P Nicklin, C Walker, DC Budd, J Pepke-Zaba… - Circulation, 2010 - Am Heart Assoc
Background— Inflammation is a feature of pulmonary arterial hypertension (PAH), and
increased circulating levels of cytokines are reported in patients with PAH. However, to date, no …
increased circulating levels of cytokines are reported in patients with PAH. However, to date, no …
ERS statement on chronic thromboembolic pulmonary hypertension
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries …
pulmonary embolism, either symptomatic or not. The occlusion of proximal pulmonary arteries …
[HTML][HTML] Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease
…, CA Clelland, J Pepke-Zaba… - … England Journal of …, 1991 - Mass Medical Soc
Background. Endothelial cells release endothelium-derived relaxing factor (EDRF) in a
variety of vascular beds, including the pulmonary circulation. However, the role of EDRF-…
variety of vascular beds, including the pulmonary circulation. However, the role of EDRF-…
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic …
…, MM Hoeper, IM Lang, E Mayer, J Pepke-Zaba… - Journal of the American …, 2008 - jacc.org
Objectives : Our goal was to investigate the effect of treatment with the oral dual endothelin
receptor antagonist bosentan on the hemodynamics and exercise capacity of patients with …
receptor antagonist bosentan on the hemodynamics and exercise capacity of patients with …
Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry
M Delcroix, I Lang, J Pepke-Zaba, P Jansa… - Circulation, 2016 - Am Heart Assoc
Background— Chronic thromboembolic pulmonary hypertension, a rare complication of acute
pulmonary embolism, is characterized by fibrothrombotic obstructions of large pulmonary …
pulmonary embolism, is characterized by fibrothrombotic obstructions of large pulmonary …